Pinealon

Pinealon, also known as the EDR peptide or Pinealon bioregulator, is a tripeptide bioregulator composed of glutamic acid, aspartic acid, and arginine (Glu-Asp-Arg). This research compound is classified as a bioregulator and has been the subject of investigation for its potential effects on pineal gland function and circadian rhythm regulation in laboratory studies. According to Khavinson bioregulation theory, Pinealon is proposed to interact directly with DNA sequences in pineal gland cells, modulating the transcription of genes involved in pineal hormone biosynthesis. Research models suggest the peptide may influence the expression of key enzymes including arylalkylamine N-acetyltransferase (AANAT) and hydroxyindole-O-methyltransferase (HIOMT), which are critical components of the pineal hormone synthesis pathway. The proposed mechanism involves the tripeptide's ability to penetrate cell membranes and nuclear envelopes due to its small molecular size, potentially influencing chromatin condensation and gene accessibility in pinealocytes. Studies indicate this may help restore pineal hormone production capacity that naturally declines with age in research models. Primary research effects observed in laboratory studies include potential support for pineal hormone synthesis, proposed circadian rhythm regulation, potential neuroprotective effects, theoretical cellular senescence pineal support, and possible improvements in sleep quality parameters. However, evidence for Pinealon remains limited primarily to in vitro and animal studies conducted by the Khavinson research group, with preclinical data suggesting the EDR peptide can influence gene expression in brain tissue and may demonstrate neuroprotective properties in cell culture models of oxidative stress. No rigorous human clinical trials have been published in internationally peer-reviewed journals, resulting in a D-grade evidence classification.